Literature DB >> 25812694

OCT4B modulates OCT4A expression as ceRNA in tumor cells.

Dong Li1, Zheng-Kai Yang1, Jing-Yi Bu1, Chun-Yan Xu1, Hui Sun1, Jie-Bing Tang1, Ping Lin1, Wen Cheng2, Ning Huang1, Rong-Jun Cui1, Xiao-Guang Yu1, Xiu-Lan Zheng2.   

Abstract

OCT4 is an essential transcription factor for maintaining the self-renewal and the pluripotency of embryonic stem cells (ESCs). The human OCT4 gene can generate three mRNA isoforms (OCT4A, OCT4B and OCT4B1) by alternative splicing. OCT4A protein is a transcription factor for the stemness of ESCs, while the function of OCT4B isoforms remains unclear. Most types of cancer express a relatively low level of OCT4 protein, particularly the OCT4B isoforms. In the present study, we found that OCT4A and OCT4B mRNA were co-expressed in several types of tumor cell lines and tumor samples, and we demonstrated that OCT4B functioned as a non-coding RNA, modulating OCT4A expression in an miRNA-dependent manner [competing endogenous RNA (ceRNA) regulation] at the post-transcription level in the tumor cell lines. This is the first time that ceRNA regulation was observed among spliced isoforms of one gene, and may pave the way for identification of new targets for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25812694     DOI: 10.3892/or.2015.3862

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  The Emerging Function and Mechanism of ceRNAs in Cancer.

Authors:  Yunfei Wang; Jiakai Hou; Dandan He; Ming Sun; Peng Zhang; Yonghao Yu; Yiwen Chen
Journal:  Trends Genet       Date:  2016-02-24       Impact factor: 11.639

Review 2.  Endogenous microRNA sponges: evidence and controversy.

Authors:  Daniel W Thomson; Marcel E Dinger
Journal:  Nat Rev Genet       Date:  2016-04-04       Impact factor: 53.242

Review 3.  Role of OCT4 in cancer stem-like cells and chemotherapy resistance.

Authors:  Ismail S Mohiuddin; Sung-Jen Wei; Min H Kang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-21       Impact factor: 5.187

Review 4.  Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer.

Authors:  Madhuvanthi Giridharan; Vasu Rupani; Satarupa Banerjee
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-30

5.  Linc-ROR has a Potential ceRNA Activity for OCT4A by Sequestering miR-335-5p in the HEK293T Cell Line.

Authors:  Elham Taheri Bajgan; Akram Gholipour; Mohammadali Faghihi; Seyed Javad Mowla; Mahshid Malakootian
Journal:  Biochem Genet       Date:  2021-10-20       Impact factor: 1.890

Review 6.  The emerging roles of Oct4 in tumor-initiating cells.

Authors:  Ying-Jie Wang; Meenhard Herlyn
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

7.  OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.

Authors:  Lu Meng; Hongyu Hu; Huifang Zhi; Yue Liu; Fangyu Shi; Laiguang Zhang; Yanjun Zhou; Aixing Lin
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

8.  Specific detection of OCT4 isoforms in inflammatory bowel disease.

Authors:  Maria Maragkoudaki; Anna Vaiopoulou; George E Theodoropoulos; Evangelia Legaki; Leonardo A Sechi; George Karamanolis; George Zografos; Maria Gazouli
Journal:  Gut Pathog       Date:  2015-10-01       Impact factor: 4.181

Review 9.  Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives.

Authors:  Chao Yang; Di Wu; Lin Gao; Xi Liu; Yinji Jin; Dong Wang; Tianzhen Wang; Xiaobo Li
Journal:  Oncotarget       Date:  2016-03-22

10.  Down-regulation of HSP40 gene family following OCT4B1 suppression in human tumor cell lines.

Authors:  Mohammad Reza Mirzaei; MalekHosein Asadi; Seyed Javad Mowla; Gholamhossin Hassanshahi; Zahra Ahmadi
Journal:  Iran J Basic Med Sci       Date:  2016-02       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.